Zimmer Biomet Holdings, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZBH | GMED | 1789.HK | 2190.HK | 0853.HK | IRTC | |
|---|---|---|---|---|---|---|
| Market cap | 21.01B | 11.69B | 4.88B | 6.45B | 11.62B | 4.42B |
| P/E (TTM) | 27.8 | 22.3 | 12.2 | 18.3 | — | — |
| Forward P/E | 12.2 | 16.2 | 9.4 | 11.4 | 23.3 | 112.0 |
| Price/book | 1.7 | 2.5 | 1.6 | 1.9 | 1.5 | 23.7 |
| Dividend yield | 0.87% | — | 2.62% | 1.30% | — | — |
| 1-year change | +10.86% | +29.38% | −21.60% | −18.44% | −46.33% | −29.99% |
| Today | +13.49% | +9.45% | +2.67% | +1.19% | 0.00% | +6.04% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All ZBH news ›Zimmer Biomet Soars 15% as Hip and Tech Growth Lifts Guidance, “Validating the Progress” of Its Strategy
Zimmer Biomet (ZBH) jumped 15% today after a third-quarter beat and a raised full-year outlook. Its rivals rallied too: Stryker (SYK) is up 8%, and Smith & Nephew (SNN) is up 7% even after cutting its own outlook this morning. Smith &…
Zimmer Biomet Non-GAAP EPS of $1.90 beats by $0.02, revenue of $2.06B beats by $20M, raises FY guidance
Zimmer Biomet beats Q3 EPS and revenue estimates, raises 2026 revenue outlook, and lifts organic growth guidance. - Zimmer Biomet press release (ZBH): Q3 Non-GAAP EPS of $1.90 beats by $0.02. - Revenue of $2.06B (+3.0% Y/Y) beats by $20M.…
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST David DeMartino - Senior Vice President of Investor RelationsIvan Tornos - President, CEO & Chairman of the BoardPaul Stellato - Interim CFO, VP,…
Zimmer raises sales forecast despite slower knee business
CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week. Orthopedics firm Zimmer Biomet raised its sales forecast for the year, despite reporting slower than…
Zimmer Biomet (NYSE:ZBH) Posts Quarterly Earnings Results
Posted by Danessa Lincoln on Nov 4th, 2026 Here are the key takeaways from Zimmer Biomet’s conference call: The firm also recently announced a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday,…
Zimmer Biomet Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
Zimmer Biomet Holdings, Inc. ZBH reported third-quarter 2026 adjusted earnings per share (EPS) of $1.90, which beat the Zacks Consensus Estimate by 0.5%. The adjusted figure has remained unchanged year over year. GAAP earnings declined…
Zimmer Biomet Announces Third Quarter 2026 Financial Results
Nov 04, 2026, 06:30 ET Geographic and Product Category Sales NET SALES - THREE MONTHS ENDED SEPTEMBER 30, 2026 Technology & Data, Bone Cement and Surgical NET SALES - NINE MONTHS ENDED SEPTEMBER 30, 2026 Amounts reported in millions are…
Mike Stern Joins Zimmer As Director of Programming.
Zimmer Communications names radio programming veteran Mike Stern Director of Programming, effective Nov. 16. Stern joins the Missouri-based broadcaster after 13 years at Jacobs Media, where he served as a consultant. In his new role, Stern…
Top Players Zimmer Biomet, and Blatchford Drive the Orthopedic Prosthetic Device Market Toward USD 4.0 Billion by 2036
Top Players Zimmer Biomet, and Blatchford Drive the Orthopedic openPR.com Top Players Zimmer Biomet, and Blatchford Drive the Orthopedic Prosthetic Device Market Toward USD 4.0 Billion by 2036 Press release from: Future Market Insights…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com8
- tradingview.com4
- openpr.com3
- prnewswire.com3
- barchart.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 50 articles, not a forecast.